ARCHIVES

OMB Reprogramming Ban Criticized

This article is from The Cancer Letter archive.

Vol. 11 No. 36 | September 20, 1985

Download PDF Visit The Full Archive

Related Articles

Novartis Submits Gleevec Data To FDA Seeking Approval For Use In GI Tumors.

October 26, 2001

Nutrition, Disease Oriented Contracts

December 4, 1981

In Brief: Lawsuit Could Delay Diet-Nutrition Cregs; Hugh Davis Replaces Mercado As CIB Chief

June 18, 1976

In Brief: AACR Award Lectures, Announced; Hungerford Honored for Philadelphia Chromosome Discovery

April 20, 1990

Mason Asks For Better Technology Transfer In Cancer Prevention

October 30, 1992

NCI Director Declines To Fund P-4 Breast Cancer Chemoprevention Trial.

June 22, 2007